NCT06744998View on ClinicalTrials.gov

Hemopatch Implication After Axillary Dissection for Breast Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Breast Cancer
Interventions
DEVICE

Hemopatch® (Baxter)

HEMOPATCH® is an absorbable collagen pad intended for sealing and hemostasis

Trial Locations (1)

20141

European Institute of Oncology, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER